Longitude Capital
Status
ACTIVE
Global HQ
Menlo Park, USA
Countries of investment
- USA
Investment stages
- Seed
- Series B
Industries
- Health Tech
- AI
- Biotechnology
- Data Science
About
Longitude Capital is a leading healthcare venture capital firm specializing in growth investments within the biotechnology, medical technology, and health solutions sectors. With a commitment to advancing innovative companies, Longitude Capital seeks to enhance clinical outcomes and improve patient quality of life through strategic financial support and expert guidance. The firm leverages its deep industry knowledge and extensive network to identify and nurture promising technologies that address pressing healthcare challenges, ultimately driving progress in medical treatment and patient care. By partnering with visionary entrepreneurs, Longitude Capital aims to transform the landscape of healthcare and foster a healthier future for all.
Longitude Capital is a leading healthcare venture capital firm specializing in growth investments within the biotechnology, medical technology, and health solutions sectors. With a commitment to advancing innovative companies, Longitude Capital seeks to enhance clinical outcomes and improve patient quality of life through strategic financial support and expert guidance. The firm leverages its deep industry knowledge and extensive network to identify and nurture promising technologies that address pressing healthcare challenges, ultimately driving progress in medical treatment and patient care. By partnering with visionary entrepreneurs, Longitude Capital aims to transform the landscape of healthcare and foster a healthier future for all.
Investment Thesis
Longitude Capital specializes in making venture growth investments in biotechnology, medical technology, and health solutions companies that seek to improve clinical outcomes, enhance patient quality of life, and reduce the cost of care.
Manager's Experience
With extensive experience in private equity, the fund manager has successfully executed over 30 deals, primarily targeting the technology and healthcare sectors in North America and Europe. Backed by a data-driven investment strategy, the focus lies on growth-stage companies, enabling strategic advancements through operator-first insights. Notable exits have included landmark transactions that enhance the firm's reputation in the market. The manager's thematic approach emphasizes innovation and sustainability, positioning the portfolio for long-term success.
Team
Patrick Enright
Patrick Enright
Marc Galletti
Maggie Jamison
Juliet Bakker
Gregory Grunberg
David Hirsch
Zander Liem
Sandip Agarwala
Oren Isacoff